Mumbai-based Ipca Laboratories Ltd plans to
acquire a pharmaceutical company in Indonesia with a view to enter the largest
South-East Asian market.
The company has put together a USD 20 million war-chest for the acquisition, to be made within the next few months, said Kuala Lumpur-based Sugumaran, adding that a number of companies have been shortlisted, though he kept the names confidential.
The seminar was addressed by several pharmaceutical companies and officials from India and Singapore, including Deputy Drug Controller of India A K Pradhan.
Eleven Indian companies participated in the seminar, where elaborate discussions were held on India-Singapore pharmaceutical trade under the Comprehensive Economic Cooperation Agreement.
Over 100 delegates attended the seminar, which was also addressed by Singapore's Economic Development Board and the Health Sciences Authority.
The company has put together a USD 20 million war-chest for the acquisition, to be made within the next few months, said Kuala Lumpur-based Sugumaran, adding that a number of companies have been shortlisted, though he kept the names confidential.
The seminar was addressed by several pharmaceutical companies and officials from India and Singapore, including Deputy Drug Controller of India A K Pradhan.
Eleven Indian companies participated in the seminar, where elaborate discussions were held on India-Singapore pharmaceutical trade under the Comprehensive Economic Cooperation Agreement.
Over 100 delegates attended the seminar, which was also addressed by Singapore's Economic Development Board and the Health Sciences Authority.
No comments:
Post a Comment